Drug Approval | June 02, 2026
Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma
The approval is supported by results from the Phase 3 SWOG 1826 trial
The approval is supported by results from the Phase 3 SWOG 1826 trial
World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The company plans to establish similar healthcare centres across universities, schools, and corporate campuses nationwide
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
A one-shot gene-editing cholesterol therapy could soon be a reality
Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023
Highlights strong Vibegron results in older men & real-world prostate cancer insights
Subscribe To Our Newsletter & Stay Updated
